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OBJECTIVE—An adverse intrauterine environment indicated
by both low birth weight and monozygosity is associated with an
age- or time-dependent reduction in glucose disposal and non-
oxidative glucose metabolism in twins, suggesting impaired
regulation of muscle glycogen synthesis.
RESEARCH DESIGN AND METHODS—We measured the
activities of glycogen synthase (GS), GS kinase (GSK)3, GS
phosphorylation, and glycogen levels in muscle biopsies ob-
tained from 184 young and elderly twins before and after a
euglycemic-hyperinsulinemic clamp.
RESULTS—Elderly monozygotic twins had significantly lower
fractional GS activity amidst higher glycogen and GS protein
levels compared with dizygotic twins. In addition, we demon-
strated strong nongenetic associations between birth weight and
defect muscle glycogen metabolism in elderly—but not in young-
er—twins. Thus, for every 100 g increase in birth weight within
pairs, GS fractional activity, GS protein level, and glycogen
content was increased by 4.2, 8.7, and 4.5%, respectively, in
elderly twins. Similarly, for every 100 g increase in birth weight,
GSK3 activity and GS phosphorylation at the sites 2, 22a, and
3a3b were decreased by 3.1, 9.0, 10.1, and 9.5%, respectively.
CONCLUSIONS—The age- or time-dependent nongenetic im-
pact of birth weight on insulin action in twins may partly be
explained by reduced insulin activation of muscle GS, mediated
through increased GSK3 activity and GS phosphorylation. Re-
duced GS activity and negative feedback inhibition of glycogen
metabolism by glycogen per se may contribute to the insulin
resistance in elderly monozygotic compared with dizygotic
twins. Diabetes 56:2710–2714, 2007
A dverse fetal environment as indicated by lowbirth weight is associated with an increasedrisk of type 2 diabetes and insulin resistance inadult life (1,2). We have previously reported a
nongenetic influence of birth weight on the development
of type 2 diabetes (3) and the underlying pathophysiolog-
ical mechanisms, including peripheral insulin resistance
among elderly twins (4). In addition, monozygosity is
associated with a reduced glucose disposal and nonoxida-
tive glucose metabolism (NOGM) in elderly twins, inde-
pendent of birth weight (5). Monozygotic twins are
exposed to a different and possibly more adverse fetal
environment compared with dizygotic twins due to the
vascular, placental, and nutritive circumstances character-
izing monozygotic pregnancies (6).
Glycogen storage accounts for the quantitatively largest
proportion of muscle glucose metabolism during insulin
infusion in the physiological range in normal subjects and
similarly represents a major defect of muscle glucose
metabolism in insulin-resistant states, including first-
degree relatives of patients with type 2 diabetes (7–9).
Insulin activates muscle glycogen synthase (GS) enzyme
activity by reducing its phosphorylation state, particularly
at the site 3a3b (10,11). A key insulin-regulated enzyme
responsible for the phosphorylation (and thereby inactiva-
tion) of GS is GS kinase (GSK)3 (12,13).
Using the classical twin approach, we recently demon-
strated a predominant environmental influence on muscle
GS activity (14). Defective GS activity or regulation may in
theory represent a molecular mechanism linking adverse
fetal environment and insulin resistance in skeletal mus-
cle. The present report represents an expansion of our
twin study, focusing explicitly on the impact of zygosity
status and birth weight on skeletal muscle GS activation
and regulation in young and elderly monozygotic and
dizygotic twins. In particular, studying twins takes advan-
tage of the genetic similarity within monozygotic twins
and is therefore an instrumental tool in discriminating
between associations of genetic and nongenetic origin.
RESEARCH DESIGN AND METHODS
Young (aged 22–31 years) and elderly (aged 57–66 years) same-sex monozy-
gotic and dizygotic twin pairs were identified through the Danish Twin
Register as described (4,5,14). Twins with available original midwife records,
including birth weight, were enrolled in the clinical examination. All twins
were born at term (3 weeks) and without known diabetes, serious disease,
or medication influencing glucose or lipid metabolism that could not be
withdrawn. The influence of heredity, birth weight, twin, and zygosity status
on insulin secretion and peripheral and hepatic insulin sensitivity has previ-
ously been reported (5,14,15). Measures of protein and enzyme activity in
skeletal muscle were achieved for a total of 184 young (monozygotic n  63;
dizygotic n  38) and elderly (monozygotic n  40; dizygotic n  43) twins.
Zygosity was determined by polymorphic genetic markers (15). The study was
approved by the regional ethical committee and conducted according to the
principles of the Declaration of Helsinki.
Clinical examination. Subjects underwent a 2-h (40 mU/m2 per min)
hyperinsulinemic-euglycemic clamp including indirect calorimetry as previ-
ously described (5,14,15). Muscle biopsies were taken from the vastus lateralis
muscle during the basal and insulin-stimulated steady-state periods, which
were defined as the last 30 min of the basal and clamp periods, respectively.
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The biopsy specimens were quickly blotted on filter paper and frozen in liquid
nitrogen. The biopsies were stored at 80°C until further processed.
In vitro experiments. Methods to determine muscle glycogen content, GS
protein expression, total and fractional GS, and GSK3 activities have
previously been described in detail (14).
Statistical methods. Comparisons between monozygotic and dizygotic twins
were performed with an ANOVA using PROC MIXED of the SAS/STAT system.
Monozygotic twins share their entire genome and dizygotic half of their
genome, which is why it may be questioned whether twins are independent
observations. Accordingly, we have adjusted for this intra–twin-pair relation-
ship. The full ANOVA model included a random-effect term for twin-pair
membership and fixed-effect terms for zygosity (5).
The linear regression analyses using monozygotic twin intrapair differences
in birth weight and measures of GS activity and regulation were performed
using SigmaStat 3.0.
RESULTS
Insulin action and relation to GS activity and regu-
lation. Birth and adult anthropometry was similar in
monozygotic and dizygotic twins in both age-groups. Insu-
lin action was similar in young monozygotic and dizygotic
twins, whereas elderly monozygotic twins had signifi-
cantly lower glucose disposal (Rd) and NOGM compared
with dizygotic twins, as previously reported (4) (Table 1).
Rd and NOGM were significantly associated with GS
fractional activity (Rd: r  0.36, P  0.00001; NOGM: r 
0.38, P  0.00001) and GS phosphorylation at site 22a
(Rd: r  0.17, P  0.02; NOGM: r  0.15, P  0.045)
(Fig. 1). Glycogen and GS protein content, total GS, and
GSK3 activity—together with GS phosphorylation at sites
2 and 3a3b—were not associated with in vivo measures
of insulin action (data not shown).
Impact of zygosity on GS activity and regulation. All
measures of GS activity and regulation were similar in
younger monozygotic and dizygotic twins (Table 2). El-
derly monozygotic twins had significantly higher glycogen
content and GS protein expression during both steady-
state periods but lower insulin-stimulated fractional GS
activity compared with dizygotic twins (Table 2).
Nongenetic influence of birth weight. Regression anal-
yses using intra–twin-pair differences were performed in
monozygotic twins to determine the quantitative magni-
tude of the nongenetic influence of birth weight on muscle
glycogen metabolism. In elderly twins, a 100 g increase in
birth weight within a pair was associated with substantial
increments in basal GS protein and glycogen contents
(mean  SE 8.7  3.2 and 4.5  1.0%, P  0.01 and P 
0.001, respectively), as well as in basal and insulin-stimu-
lated GS fractional activities (5.3 2.0 and 4.2 2.0%, P
0.01 and P  0.046, respectively). Similarly, for each 100 g
increase in intrapair birth weight, marked reductions of
insulin-stimulated GSK3 activity (3.1  0.8%, P  0.001)
and the degree of GS phosphorylation at sites 2 (9.0 
2.9%, P 0.002), 22a (10.1 3.8%, P 0.007), and 3a3b
(9.5  4.3%, P  0.02) in the basal state, as well as site
3a3b during insulin infusion (5.5  2.8%, P  0.046),
were seen (Fig. 2).
In the younger monozygotic twins, a 100 g increase in
birth weight was associated with a 2.1  1.0% (P  0.044)
decrease in basal GS protein content and a 9.9 3.0% (P
0.0002) increase in GS phosphorylation at site 3a3b.
DISCUSSION
Performing analyses with intrapair differences allows ad-
justment for common environmental and maternal factors
TABLE 1
Clinical characteristics in young and elderly monozygotic and dizygotic twins
Young Elderly
Monozygotic Dizygotic P Monozygotic Dizygotic P
n 63 38 40 43
Age (years) 28.2 0.29 27.6 0.3 0.10 61.7 0.4 62.1 0.3 0.61
Birth weight (g) 2,632 68 2,571 76 0.57 2,658 61 2,722 80 0.73
BMI (kg/m2) 24.3 0.4 23.8 0.5 0.43 26.4 0.7 26.1 0.9 0.83
WHR 0.85 0.01 0.82 0.01 0.17 0.90 0.02 0.86 0.02 0.20
Body fat percentage (%) 22.5 0.9 21.8 1.1 0.62 27.9 2.0 28.4 1.8 0.87
Rd (mg  kg
1  min1) 12.1 0.5 11.1 0.5 0.14 8.9 0.6 10.8 0.6 0.02
NOGM (mg  kg1  min1) 7.4 0.4 6.5 0.4 0.10 4.9 0.5 6.7 0.5 0.03
Data are means  SE. WHR, waist-to-hip ratio.
FIG. 1. Association between metabolic rates (glucose disposal and
NOGM) and GS fractional activity (A) and GS phosphorylation at site
22a (B), respectively, in young and elderly twins (n  184).
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in both monozygotic and dizygotic twins. In addition,
genetic factors can be eliminated in monozygotic twin
pairs, permitting distinction between associations of ge-
netic and nongenetic origin. Using this design, we previ-
ously demonstrated a nongenetic positive association
between birth weight and insulin sensitivity in elderly
twins (5). In younger twins, we observed a trend toward a
paradoxical inverse association between birth weight and
insulin sensitivity, suggesting that the relationship may be
age or time dependent. In the present study, we unmasked
a quantitatively significant nongenetic impact of birth
weight on GS activity and regulation among elderly
monozygotic twin pairs. Skeletal muscle GS fractional
activity correlates closely with both glucose disposal and
NOGM and is therefore likely to represent a molecular
mechanism explaining or contributing to the link between
birth weight and insulin sensitivity in elderly twins. For
every 100 g difference in birth weight within a twin pair,
the heavier twin exhibited increments in insulin-stimu-
lated muscle fractional GS activity, GS protein, and glyco-
gen contents of between 4 and 9%, with concomitant
3–10% reductions in GSK3 activity and degree of GS
phosphorylation at sites 2, 22a, and 3a3b. This pattern
of reduced glycogen synthesis in elderly low–birth weight
twins agrees with our previously reported association
between birth weight and defects of NOGM in elderly
twins (5). Although seldom within twin pairs, a birth
weight difference of 1 kg—equivalent to the difference in
birth weight between “low birth weight” (2,500 g) sub-
jects and the average birth weight of 3,500 g in Caucasian
newborns—had a quantitative impact on insulin-stimu-
lated fractional GS activity in elderly twins comparable
with that previously observed in both patients with overt
type 2 diabetes and their first-degree relatives of20–40%
(8,9,16,17).
In the younger monozygotic twins, low birth weight was
associated with an increase in GS protein content and a
decrease in GS phosphorylation at site 3a3b. Although
neither of these variables were associated with in vivo
measures of glucose uptake and/or storage, the findings
are altogether consistent with the notion of an age- or
time-dependent nongenetic effect of birth weight on both
NOGM (5) and muscle GS activation in twins. Whether
these divergent effects of birth weight on in vivo glucose
metabolism in young and elderly twins are truly age
related (i.e., advanced age unmasks the adverse metabolic
defects associated with low birth weight) or a result of
different life and nutritional conditions during the periods
of birth (i.e., a time or cohort effect) remains to be
clarified.
Previous studies have failed to demonstrate any influ-
ence of birth weight on postprandial GS activity (18) or on
basal or insulin-stimulated GS gene expression levels (19)
in relatively young human subjects. The significant posi-
tive association between birth weight and muscle glycogen
content in elderly twins in the present study is consistent
with studies reporting reduced muscle and liver glycogen
contents in rats exposed to protein restriction during fetal
TABLE 2
Measures of GS activity and regulation during the basal and insulin-stimulated steady-state periods in young and elderly monozygotic
and dizygotic twins
Young Elderly
Monozygotic Dizygotic P Monozygotic Dizygotic P
n 63 38 40 43
Basal
Glycogen (mmol/kg ww muscle) 92.0 3.7 86.0 3.7 0.25 94.8 4.6 81.0 4.2 0.033
GS total protein (AU) 656.3 43.2 659.3 51.3 0.96 703.8 69.2 522.1 56.8 0.049
GS total activity (mmol  min1  kg1) 4.81 0.13 4.99 0.18 0.41 4.20 0.19 4.02 0.21 0.55
GS fractional activity (% FV) 17.25 0.96 15.5 0.98 0.21 15.5 1.05 17.5 1.05 0.19
pGS site 3a3b (AU) 0.29 0.03 0.24 0.03 0.25 0.23 0.03 0.26 0.03 0.32
pGS site 2 (AU) 1.01 0.08 1.11 0.09 0.46 1.01 0.11 1.10 0.09 0.51
pGS site 22a (AU) 3.75 0.35 4.32 0.44 0.33 3.96 0.64 4.09 0.50 0.88
GSK3 activity (nmol  min1  mg1) 5.11 0.19 4.82 0.16 0.24 5.20 0.25 5.18 0.19 0.94
Insulin
Glycogen (mmol/kg ww muscle) 93.4 3.5 87.3 3.7 0.24 92.1 3.6 80.7 4.1 0.04
GS total protein (AU) 582.8 40.0 574.5 58.3 0.91 617.1 75.9 401.1 48.2 0.022
GS total activity (mmol  min1  kg1) 5.01 0.16 5.00 0.20 0.97 4.42 0.19 3.91 0.20 0.07
GS fractional activity (% FV) 33.7 1.4 31.0 1.4 0.17 29.4 1.7 34.8 1.6 0.028
pGS site 3a3b (AU) 0.17 0.02 0.17 0.02 0.99 0.15 0.02 0.15 0.01 0.88
pGS site 2 (AU) 1.16 0.10 1.30 0.09 0.32 1.15 0.10 1.24 0.13 0.55
pGS site 22a (AU) 2.79 0.24 3.36 0.37 0.21 3.30 0.44 3.39 0.41 0.87
GSK3 activity (nmol  min1  mg1) 3.50 0.14 3.46 0.13 0.82 3.76 0.16 3.52 0.17 0.31
Data are means  SE. AU, arbitrary units; FV, fractional velocity.
FIG. 2. Percentage change in GS activity and regulation (f, decrease;
p, increase) for each 100 g increase in within-pair birth weight in
elderly monozygotic twins. Data are percent (SE).
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life (20,21). It is likely that the lack of association between
birth weight and GS activity and regulation in previous
human studies may be explained by a relatively small
number of study subjects, differences in age, and perhaps
most importantly by the failure to adjust for genetic
influence (18,19). The defect in GS activity associated with
low birth weight is mediated by increased GSK3 activity
and GS phosphorylation and may represent an indepen-
dent mechanism linking fetal environment and insulin
resistance or may operate in concert with additional
underlying defects of insulin signaling. Indeed, we have
previously demonstrated an inverse influence of birth
weight on GLUT4 (22) and transcriptional coactivator
peroxisome proliferator–activated  coactivator-1 (23) in
twins, as well as on expression levels of specific proteins
involved in insulin signaling in young low–birth weight
subjects compared with control subjects (24).
Monozygotic twins are exposed to a different and pos-
sibly more adverse fetal environment compared with
dizygotic twins due to the fact that they often share the
same placenta (6). Consistent with the thrifty phenotype
hypothesis, this may explain our previous finding that
there is insulin resistance in elderly monozygotic com-
pared with dizygotic twins (4,5) and, in the present con-
text, as well as decreased fractional GS activity in elderly
monozygotic compared with dizygotic twins. Accordingly,
the lower glucose disposal and NOGM in the elderly
monozygotic twins may be explained by reduced frac-
tional GS activity. Interestingly, elderly monozygotic twins
had a somewhat surprisingly increased GS protein expres-
sion and glycogen content compared with elderly dizygotic
twins. While the increased GS protein expression may
represent a compensatory mechanism, the elevated mus-
cle glycogen content could at least partly be responsible
for the reduced GS fractional activity due to negative
feedback inhibition by increased glycogen content. Al-
though type 2 diabetes in most studies is characterized by
reduced glycogen content, increased glycogen content
induced by overfeeding and inactivity may contribute to
reduced insulin action (25,26). In addition, it was recently
demonstrated that an increased glycogen–to–oxidative
enzyme activity relationship may contribute to insulin
resistance (26). In support of this view, the muscle glyco-
gen level was associated in a negative manner with GS
fractional activity (r  0.33, P  0.00001), which in turn
was associated to insulin action.
Our findings suggest that programming in utero influ-
ences GS activity and glycogen synthesis in elderly twins
in different ways. Importantly, the effect of zygosity is
independent of and goes beyond the effect of birth weight,
and we believe that our findings represent an illustrative
example of the diverse and sometimes apparently oppos-
ing effects of two surrogate measures of the fetal environ-
ment (i.e., zygosity and birth weight) on adult phenotype.
In conclusion, we provide evidence for a major role of
the fetal environment in the regulation of GS activity and
glycogen metabolism in skeletal muscle. The age- or
time-dependent nongenetic impact of birth weight on
insulin action and NOGM in twins may partly be explained
by reduced insulin activation of GS activity. This effect is
mediated through increased GSK3 activity and phosphor-
ylation of GS at sites 2, 22a, and 3a3b. Reduced GS
activity and negative feedback inhibition of glycogen me-
tabolism by glycogen may contribute to the insulin resis-
tance in elderly monozygotic compared with dizygotic
twins.
REFERENCES
1. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD:
Fetal and infant growth and impaired glucose tolerance at age 64. BMJ
303:1019–1022, 1991
2. McMillen IC, Robinson JS: Developmental origins of the metabolic syn-
drome: prediction, plasticity, and programming. Physiol Rev 85:571–633,
2005
3. Poulsen P, Vaag AA, Kyvik KO, Jensen DM, Beck-Nielsen H: Low birth
weight is associated with NIDDM in discordant monozygotic and dizygotic
twin pairs. Diabetologia 40:439–446, 1997
4. Poulsen P, Levin K, Beck-Nielsen H, Vaag A: Impact of age and zygosity on
in vivo insulin action and insulin scretion in twins. Diabetologia 45:1649–
1657, 2002
5. Poulsen P, Vaag A: The intrauterine environment as reflected by birth size,
twin, and zygosity status influences insulin action and intracellular glucose
metabolism in an age- or time-dependent manner. Diabetes 55:1819–1825,
2006
6. Hall JG: Twinning. Lancet 362:735–743, 2003
7. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG:
Quantitation of muscle glycogen synthesis in normal subjects and subjects
with non-insulin-dependent diabetes by 13C nuclear magnetic resonance
spectroscopy. N Engl J Med 322:223–228, 1990
8. Damsbo P, Vaag A, Hother-Nielsen O, Beck-Nielsen H: Reduced glycogen
synthase activity in skeletal muscle from obese patients with and without type
2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:239–245, 1991
9. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of
glycogen synthase in skeletal muscles in young nonobese Caucasian
first-degree relatives of patients with non-insulin-dependent diabetes mel-
litus. J Clin Invest 89:782–788, 1992
10. Lawrence JC Jr, Roach PJ: New insights into the role and mechanism of
glycogen synthase activation by insulin. Diabetes 46:541–547, 1997
11. Hojlund K, Staehr P, Hansen BF, Green KA, Hardie DG, Richter EA,
Beck-Nielsen H, Wojtaszewski JF: Increased phosphorylation of skeletal
muscle glycogen synthase at NH2-terminal sites during physiological
hyperinsulinemia in type 2 diabetes. Diabetes 52:1393–1402, 2003
12. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition
of glycogen synthase kinase-3 by insulin mediated by protein kinase B.
Nature 378:785–789, 1995
13. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R,
Alessi DR: Role that phosphorylation of GSK3	 plays in insulin and Wnt
signalling defined by knockin analysis. EMBO J 24:1571–1583, 2005
14. Poulsen P, Wojtaszewski J, Richter E, Beck-Nielsen H, Vaag A: Etiology of
muscle glycogen synthase activity and regulation: a twin study. Diabetes
54:1289–1296, 2005
15. Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A:
Heritability of insulin secretion, peripheral and hepatic insulin action, and
intracellular glucose partitioning in young and old Danish twins. Diabetes
54:275–283, 2005
16. Vestergaard H, Lund S, Larsen FS, Bjerrum OJ, Pedersen O: Glycogen
synthase and phosphofructokinase protein and mRNA levels in skeletal
muscle from insulin-resistant patients with non-insulin-dependent diabetes
mellitus. J Clin Invest 91:2342–2350, 1993
17. Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR:
Potential role of glycogen synthase kinase-3 in skeletal muscle insulin
resistance of type 2 diabetes. Diabetes 49:263–271, 2000
18. Phillips DI, Borthwick AC, Stein C, Taylor R: Fetal growth and insulin
resistance in adult life: relationship between glycogen synthase activity in
adult skeletal muscle and birthweight. Diabet Med 13:325–329, 1996
19. Jaquet D, Vidal H, Hankard R, Czernichow P, Levy-Marchal C: Impaired
regulation of glucose transporter 4 gene expression in insulin resistance
associated with in utero undernutrition. J Clin Endocrinol Metab 86:3266–
3271, 2001
20. Murphy HC, Regan G, Bogdarina IG, Clark AJ, Iles RA, Cohen RD, Hitman
GA, Berry CL, Coade Z, Petry CJ, Burns SP: Fetal programming of
perivenous glucose uptake reveals a regulatory mechanism governing
hepatic glucose output during refeeding. Diabetes 52:1326–1332, 2003
21. Selak MA, Storey BT, Peterside I, Simmons RA: Impaired oxidative
phosphorylation in skeletal muscle of intrauterine growth-retarded rats.
Am J Physiol Endocrinol Metab 285:E130–E137, 2003
22. Storgaard H, Poulsen P, Ling C, Groop L, Vaag AA: Genetic and nongenetic
determinants of skeletal muscle glucose transporter 4 messenger ribonu-
cleic acid levels and insulin action in twins. J Clin Endocrinol Metab
91:702–708, 2006
23. Ling C, Poulsen P, Carlsson E, Ridderstråle M, Beck-Nielsen H, Groop L,
Vaag A: Multiple environmental and genetic factors influence skeletal
P. POULSEN AND ASSOCIATES
DIABETES, VOL. 56, NOVEMBER 2007 2713
muscle PGC-1alpha and PGC-1beta gene expression in twins. J Clin Invest
114:1518–1526, 2004
24. Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S, Vaag A: Low
birthweight is associated with specific changes in muscle insulin-signalling
protein expression. Diabetologia 48:547–552, 2005
25. Mott DM, Lillioja S, Bogardus C: Overnutrition induced decrease in insulin
action for glucose storage: in vivo and in vitro in man. Metabolism
35:160–165, 1986
26. He J, Kelley DE: Muscle glycogen content in type 2 diabetes mellitus. Am J
Physiol Endocrinol Metab 287:E1002–E1007, 2004
FETAL ENVIRONMENT AND GLYCOGEN SYNTHASE REGULATION
2714 DIABETES, VOL. 56, NOVEMBER 2007
